Related Experiment Video
Updated: May 12, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Good's Syndrome Complicated with COVID-19 and Recurrent Pulmonary Infections: A Case Report
Wenjuan Xia1, Mengqi Wu2, Fang He3
1Department of Respiratory and Critical Care Medicine, Anhui Chest Hospital, Hefei, China. wenjuanx616@163.com.
Good's syndrome (GS), a rare immunodeficiency, requires early diagnosis by integrating thymoma history, immune status, and pathogen identification. Prompt treatment with immunoglobulin replacement and targeted therapies improves outcomes in complex infections.
Area of Science:
- Immunology
- Infectious Diseases
- Oncology
Background:
- Good's syndrome (GS) is a rare primary immunodeficiency characterized by thymoma and hypogammaglobulinemia.
- GS presents diagnostic and therapeutic challenges, often leading to recurrent infections.
- Delayed diagnosis can result from overlooking key clinical and immunological features.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction